BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma (clinicaltrials.gov) - Oct 8, 2026 - P1 | N=20 | Completed | Sponsor: Memorial Sloan Kettering Cancer Center | Active, not recruiting ➔ Completed | Trial completion date: Feb 2027 ➔ Oct 2026 | Trial primary completion date: Feb 2027 ➔ Oct 2026
Trial completion • Trial completion date • Trial primary completion date • Hematological Malignancies • Multiple Myeloma • Oncology
|